New $22M Study to Use Sequencing, Proteomics to Investigate Pulmonary Fibrosis

Nov 04, 2019

|

NEW YORK — The Pulmonary Fibrosis Foundation (PFF) announced today the start of a study, supported by $22 million in funding from the National Institutes of Health and philanthropic organization Three Lakes Partners, using genomics and other technologies to diagnose and treat idiopathic pulmonary fibrosis (IPF).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

New $22M Study to Use Sequencing, Proteomics to Investigate Pulmonary Fibrosis

To read the full story....

Breaking News

Color Gears Up to Enter COVID-19 Testing Space

Exact Sciences, Promega Aiding in COVID-19 Testing in Wisconsin

Cue Health Awarded $13M BARDA Contract for POC Coronavirus Test

Luminex Receives Second BARDA Contract for $642K to Develop Rapid SARS-CoV-2 Test

Thermo Fisher Scientific Prices €1.2B Senior Notes Offering

Depression GWAS Based on Minimal Phenotyping May Lead to Skewed Results

The Scan

Finds a Whole Bunch

Away From the Field

PNAS Studies Look at Bacterial Detection Probes, Cholera Culprit Evolution in Environment, More

In a Different Lab

Featured White Papers

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

What's Popular?

COVID-19 Host Susceptibility Studies Ramp Up Internationally

SARS-CoV-2-Related Coronaviruses Found in Pangolins

Stanford Team Debuts New Liquid Biopsy Lung Cancer Screening Method

UK COVID-19 Sequencing Consortium to Reveal Viral Spread, Evolution

Rockefeller-Led Team Launches Initiative to Study COVID-19 Genetic Vulnerability

Sponsorships